** Shares of medical device maker Kestra Medical Technologies KMTS.O set to open 95% above offer price in Nasdaq debut
** Stock indicated to open at $33.15 vs $17 IPO price
** KMTS, backed by buyout firm Bain Capital, sold ~11.9 mln shares in its upsized offering - 19% more than initially offered, and above its marketed range of $14 and $16 apiece to raise $202 mln
** Listing marks first notable March IPO and the third medical device maker flotation in New York since October
** KMTS competes in the wearable cardioverter defibrillator market that has been dominated by Zoll Medical
** BofA Securities, Goldman Sachs and Piper Sandler were the lead bookrunners for the offering
(Reporting by Arasu Kannagi Basil in Bengaluru)
((ArasuKannagi.Basil@thomsonreuters.com;))
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。